JAKARTA: The national pharmaceutical company, Soho Group, is ready to inject capital of US$200 million or approximately IDR1.84 trillion for the development of pharmaceutical products in Indonesia within the next 15 years.
President Director of Soho Group, Marcus Pitt, said the investment will be used for plant construction and research of medical products that can support the firm's business.
According to him, Soho Group can ensure built a factory in Jababeka Industrial Area, Cikarang, West Java, in the second half of 2012.
Previously, he said, the company already has factory in Pulogadung, East Jakarta.
"The factory is located in Jababeka [Jababeka Industrial Estate, Cikarang, West Java] is determined to support our existing plant in Pulogadung," he said.
In the factory which has a land area of 20 hectares, he said, there is a training center for employees and product development.
Marcus said previously Soho Group product marketing strategy is done throughout multilevel marketing (MLM).
Thus, he said, it hopes to have the reliable power to market all kinds of products owned by Soho Group to consumers.
He explained the pharmaceutical market in Indonesia is still very large to be developed, along with the high demand of medical services.
The largest contribution of Soho Group’s drug sales, he said, contributed from prescription drugs for 60%.
"As for the other 40% of sales will be donated usual medication," he said.
Soho Group, he said, is also planning to add warehouse logistics in a number of areas to support their business development.
Previously, Soho Group has built logistics warehouse in Batam and Surabaya managed by a subsidiary of PT Parit Padang Global.(T03/sut)